Statins Counter the Effects of Hyperlipidemia on iNKT Cells Joel Linden EDITORIAL 29 April 2012 Pages: 277 - 279
Beyond Hyperglycemia in Diabetes: Role of Statin Treatment on Thrombogenesis Triggered by Inflammation Francesca PeregoGiovanni Davì EDITORIAL 15 May 2012 Pages: 281 - 284
Relaxant Effect of a Water Soluble Carbon Monoxide-Releasing Molecule (CORM-3) on Spontaneously Hypertensive Rat Aortas Paola FailliAlfredo VannacciEmanuela Masini OriginalPaper 06 July 2012 Pages: 285 - 292
Statin-Induced Immunomodulation Alters Peripheral Invariant Natural Killer T-cell Prevalence in Hyperlipidemic Patients Evangelia NakouProdromos BabageorgakasDimitrios A. Stakos OriginalPaper 24 March 2012 Pages: 293 - 299
Impact of Statins on the Coagulation Status of Type 2 Diabetes Patients Evaluated by a Novel Thrombin-Generation Assay P. FerroniD. Della-MorteF. Guadagni OriginalPaper 12 April 2012 Pages: 301 - 309
The Use of ω-3 Poly-Unsaturated Fatty Acids in Heart Failure: A Preferential Role in Patients with Diabetes Pedram KazemianSeyyed M. R. Kazemi-BajestaniGavin Y. Oudit ReviewPaper 30 May 2012 Pages: 311 - 320
High Molecular Weight Calmodulin-Binding Protein: 20 Years Onwards—A Potential Therapeutic Calpain Inhibitor Sreejit ParameswaranRajendra K. Sharma ReviewPaper 16 May 2012 Pages: 321 - 330
Stroke Prevention in Atrial Fibrillation: Managing the Risks in Light of New Oral Anticoagulants John E. Strobeck ReviewPaper 25 May 2012 Pages: 331 - 338
Importance of Blood Rheology in the Pathophysiology of Atherothrombosis Aimee Q. CowanDaniel J. ChoRobert S. Rosenson OriginalPaper 21 July 2012 Pages: 339 - 348
Study Design, Rationale, and Baseline Characteristics: Evaluation of Fenofibric Acid on Carotid Intima-Media Thickness in Patients with Type IIb Dyslipidemia with Residual Risk in Addition to Atorvastatin Therapy (FIRST) Trial Michael DavidsonRobert S. RosensonJames Stolzenbach OriginalPaper Open access 24 May 2012 Pages: 349 - 358
New Challenges Ahead for the Newer Oral Thrombin Inhibitors that Aim at Replacing Warfarin in Clinical Practice—Any Role for Scientific Societies in the Debate? Juan-Carlos Kaski ISCP PRESIDENT'S LETTER 05 May 2012 Pages: 359 - 360